3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow GLPG1690: new trials by email Literature Review of GLPG1690 trials Research Report on GLPG1690
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers GLPG1690, Itraconazole, Voriconazole - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 18 | 2018-03-16 | 2018-06-11 |
| Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet GLPG1690 - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 12 | 2017-04-18 | 2017-06-20 |
| First-in-Human Single and Multiple Dose of GLPG1690 GLPG1690 single ascending doses, Placebo single ascending doses, GLPG1690, multiple ascending doses, oral suspension - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 40 | 2014-06-01 | 2015-09-22 |
Lakefront Biotherapeutics NV (3)
Belgium (2) · United Kingdom (1)
Ann Fieuw, MD MSc (1) · Christopher Brearley, BM, MRCP, MFPM (1)
2014 (1), 2017 (1)